These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 4433087)

  • 21. Prothrombin complex concentrate (Beriplex P/N) for emergency anticoagulation reversal: a prospective multinational clinical trial.
    Pabinger I; Brenner B; Kalina U; Knaub S; Nagy A; Ostermann H;
    J Thromb Haemost; 2008 Apr; 6(4):622-31. PubMed ID: 18208533
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Clinical use of factor IX concentrates].
    Nyman D
    Schweiz Med Wochenschr; 1975 Sep; 105(37):1188-90. PubMed ID: 1215901
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Thrombogenicity of prothrombin complex concentrates.
    Köhler M
    Thromb Res; 1999 Aug; 95(4 Suppl 1):S13-7. PubMed ID: 10499904
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prothrombin complex concentrates and coagulation.
    Penner JA
    Ann Intern Med; 1976 Oct; 85(4):531-2. PubMed ID: 970783
    [No Abstract]   [Full Text] [Related]  

  • 25. Prothrombin overload causes thromboembolic complications in prothrombin complex concentrates: in vitro and in vivo evidence.
    Grundman C; Plesker R; Kusch M; Hanschmann KM; Eich S; Seitz R; König H
    Thromb Haemost; 2005 Dec; 94(6):1338-9. PubMed ID: 16411418
    [No Abstract]   [Full Text] [Related]  

  • 26. [Thrombosis and anti-tumor chemotherapy].
    Barbui T; Falanga A
    Haematologica; 1991 Jun; 76 Suppl 3():276-80. PubMed ID: 1752523
    [No Abstract]   [Full Text] [Related]  

  • 27. Monoclonal antibody-purified factor IX--comparative thrombogenicity to prothrombin complex concentrate.
    Kim HC; Matts L; Eisele J; Czachur M; Saidi P
    Semin Hematol; 1991 Jul; 28(3 Suppl 6):15-9. PubMed ID: 1780766
    [No Abstract]   [Full Text] [Related]  

  • 28. Serious reaction after Konyne.
    Weinreb NJ; Minsky N
    N Engl J Med; 1971 Nov; 285(20):1151-2. PubMed ID: 5095754
    [No Abstract]   [Full Text] [Related]  

  • 29. [Coronary thrombosis after hormonal contraception].
    Dalgaard JB; Gregersen M
    Beitr Gerichtl Med; 1969; 25():224-34. PubMed ID: 5821379
    [No Abstract]   [Full Text] [Related]  

  • 30. Virus safety of prothrombin complex concentrates and factor IX concentrates.
    Seitz R; Dodt J
    Thromb Res; 1999 Aug; 95(4 Suppl 1):S19-23. PubMed ID: 10499905
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Hepatitis associated with Konyne: clinico-pathologic observations of 10 cases].
    Delage C; Lagacé R
    Union Med Can; 1974 Jul; 103(7):1207-17. PubMed ID: 4842175
    [No Abstract]   [Full Text] [Related]  

  • 32. Thromboembolic disease and the steroidal content of oral contraceptives. A report to the Committee on Safety of Drugs.
    Inman WH; Vessey MP; Westerholm B; Engelund A
    Br Med J; 1970 Apr; 2(5703):203-9. PubMed ID: 5443406
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Embolism of fetal brain tissue to the lungs.
    Drut R
    Pediatr Pathol Lab Med; 1997; 17(6):987. PubMed ID: 9353841
    [No Abstract]   [Full Text] [Related]  

  • 34. Mechanism of the anticoagulant effect of warfarin as evaluated in rabbits by selective depression of individual procoagulant vitamin K-dependent clotting factors.
    Zivelin A; Rao LV; Rapaport SI
    J Clin Invest; 1993 Nov; 92(5):2131-40. PubMed ID: 8227329
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Production and composition of prothrombin complex concentrates: correlation between composition and therapeutic efficiency.
    Hellstern P
    Thromb Res; 1999 Aug; 95(4 Suppl 1):S7-12. PubMed ID: 10499903
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Thromboembolic complications associated with the use of prothrombin complex and factor IX concentrates.
    Köhler M; Hellstern P; Lechler E; Uberfuhr P; Müller-Berghaus G
    Thromb Haemost; 1998 Sep; 80(3):399-402. PubMed ID: 9759617
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Thrombosis and embolism after injury.
    Sevitt S
    J Clin Pathol Suppl (R Coll Pathol); 1970; 4():86-101. PubMed ID: 5293392
    [No Abstract]   [Full Text] [Related]  

  • 38. Thrombosis and disseminated intravascular coagulation following treatment with the prothrombin complex concentrate, DEFIX.
    Roddie PH; Stirling C; Mayne EE; Ludlam CA
    Thromb Haemost; 1999 Apr; 81(4):667. PubMed ID: 10235464
    [No Abstract]   [Full Text] [Related]  

  • 39. Thrombogenicity associated with factor IX complex concentrates.
    Lusher JM
    Semin Hematol; 1991 Jul; 28(3 Suppl 6):3-5. PubMed ID: 1780767
    [No Abstract]   [Full Text] [Related]  

  • 40. Prothrombin complex concentrates for reversal of vitamin K antagonists: assessing the risks.
    Streiff MB
    Thromb Haemost; 2011 Sep; 106(3):389-90. PubMed ID: 21833456
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.